Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Ophthalmology"
DOI: 10.1136/bjophthalmol-2018-312430
Abstract: Background/aims To investigate the factors associated with macular atrophy (MA) growth rates in neovascular age-related macular degeneration treated with either ranibizumab or aflibercept. Methods We obtained data from two identical prospective studies using ranibizumab or… read more here.
Keywords: growth rates; age; macular atrophy; ranibizumab aflibercept ... See more keywords